COVID infections drop 16% worldwide in one week: WHO
COVID infections drop 16% worldwide in one week: WHO

The number of coronavirus deaths also declined in all regions by 10 per cent over the same period, with 81,000 fatalities reported in the last week, the UN health agency said in its weekly epidemiological update on Tuesday.  

2.3 million victims 

This brings the overall number of people who died from COVID-19 to more than 2.3 million, according to WHO.  

Moreover, there were 2.7 million cases of new coronavirus infections last week, bringing that total number to just over 108 million.  

Five-out-of-six regions reported a double-digit percentage drop in the number of new cases, with Russia recording an 11 per cent decrease, the United States a 23 per cent drop and the United Kingdom a 27 per cent fall. 

Only infections in the Eastern Mediterranean Region increased, by seven per cent. 

The UN health agency data, which is gathered from its global membership, also said that the European and Americas regions continue to see the greatest drops in absolute numbers of COVID-19 cases. 

In some European countries, this is “likely (owing) to a strong combination of public health and social measures”, the UN agency said, before cautioning that the majority of European nations continue to experience “high or increasing” infection rates among older age groups “and/or high death rates”. 

It cited France, UK, Russia, US and Brazil as having the highest case tally in the past week. 

Variant spread 

Detailing the spread of the three main COVID-19 mutations, which have raised concerns over faster virus transmission and whether they are less susceptible to available vaccines, WHO said that the so-called “UK variant” (VOC 202012/01)  is now present in 94 countries across all regions – eight more than the previous week. 

The “South African variant” (VOC202012/02) has been traced in 46 countries, an increase of two, while the “Brazilian/Japanese variant” (P.1) is present in 21 countries, up by six.  

Citing genetic sampling of the UK variant, the WHO report noted that the proportion of people infected with VOC 202012/01 “has increased in the past weeks, indicating community transmission in a number of countries”. 

Downward COVID-19 trend shows ‘simple public health measures work’ – UN health chief 
Downward COVID-19 trend shows ‘simple public health measures work’ – UN health chief 

“Last week saw the lowest number of reported weekly cases since October”, Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) told journalists at a regular press briefing in Geneva.  

Noting a nearly 50 per cent drop this year, he stressed that “how we respond to this trend” is what matters now. 

While acknowledging that there is more reason for hope of bringing the pandemic under control, the WHO chief warned, “the fire is not out, but we have reduced its size”.  

“If we stop fighting it on any front, it will come roaring back”. 

‘All the pieces in place’ 

WHO gave the green light for two versions of the Oxford-AstraZeneca vaccine to be rolled out globally under an emergency listing, which assesses and assures the quality, safety and efficacy of COVID-19 vaccines and is also a distribution prerequisite under the UN-led vaccine initiative COVAX

One of the vaccines was produced by SKBio in Korea, the other by the Serum Institute of India. 

Following the Pfizer-BioNTech inoculations, these are the second and third vaccines to receive emergency use listing. 

“We now have all the pieces in place for the rapid distribution of vaccines”, said Tedros.  

However, he reiterated the need to scale-up production along with his call for vaccine developers to send their dossiers to WHO for review when they submit them to regulators in high-income countries. 

Upcoming G7 meeting 

Ensuring the rapid and equitable rollout of vaccines globally is essential for saving lives, stabilizing health systems, protecting livelihoods and steadying economies, according to the WHO chief. 

“Fully funding COVAX represents the greatest possible stimulus and is a rounding error compared with the trillions of dollars that have been mobilized in G7 countries to support their economies’, he said. 

The WHO chief looked forward to an upcoming meeting of the G7 industrialized countries on Friday to discuss vaccine equity. 

And he underscored the need to continue building the demand for vaccines by ensuring people have the right information, recalling that a year ago, “we were not only fighting a pandemic, we were fighting an infodemic”. 

The solution is to fight misinformation, delete false or misleading statements, listen to concerns and questions and provide answers with good information, Tedros upheld. 

Combatting Ebola  

Drawing attention to last week’s spate of Ebola cases in Democratic Republic of the Congo, the WHO chief emphasized that having the right information is “essential in every outbreak situation”. 

“Four cases have now been reported, and two people have died”, he updated, adding that yesterday, authorities in Guinea declared a separate Ebola outbreak in the town of Gouéké, in the country’s southeast.

“So far, three cases have been confirmed, among six people who reported Ebola like-symptoms after attending a funeral in late January”, he said. “Two have since died, while the other four are being treated in hospital”. 

He informed the journalists that although both outbreaks are in hard-to-reach, insecure areas with mistrust of outsiders, WHO is working closely with health authorities to engage affected communities to enhance trust and acceptance in both countries. 

While Ebola and COVID-19 are “two very different diseases”, Tedros said that “both thrive on misinformation and mistrust” and can both be stopped with proven public health measures, engaged communities, accurate information and vaccines. 

Three die as new Ebola outbreak declared in southern Guinea
Three die as new Ebola outbreak declared in southern Guinea

This is the first time the disease has been reported in the country since the deadly 2014-2016 outbreak in West Africa which claimed over 11,000 lives. 

“It’s a huge concern to see the resurgence of Ebola in Guinea, a country which has already suffered so much from the disease”, Matshidiso Moeti, WHO Regional Director for Africa, said

“However, banking on the expertise and experience built during the previous outbreak, health teams in Guinea are on the move to quickly trace the path of the virus and curb further infections”, she added. 

According to the UN health agency, the cases, which were confirmed by the national laboratory, occurred in Gouéké in N’Zerekore prefecture, in southern Guinea. Initial investigations found that a nurse from a local health facility died on the 28 January. Following her burial, six people who attended the funeral reported Ebola-like symptoms and two of them later died. The other four are in hospital. 

Samples of the confirmed cases have been sent to the InstitutPasteur centre in Senegal for full genome sequencing to identify the strain of the Ebola virus. 

Guinea was one of the three most-affected countries in the 2014-2016 West Africa Ebola outbreak which was the largest since the virus was first discovered in 1976. The outbreak, which saw some 28,000 cases, including 11,000 deaths, started in Guinea and then moved across land borders to Sierra Leone and Liberia.  

WHO supporting response 

Staff from WHO are already on the ground, assisting surveillance, and infection prevention and control efforts.   

“WHO is supporting the authorities to set up testing, contact-tracing and treatment structures and to bring the overall response to full speed”, Dr. Moeti said. 

WHO personnel are also reaching out to communities to ensure they take a key role in the response. In addition, the agency is also helping Guinea procure the Ebola vaccine which has proven instrumental in controlling outbreaks in the Democratic Republic of the Congo (DRC).  

As the epicentre of the current outbreak in a border area, WHO is also working with health authorities in Liberia and Sierra Leone to step up community surveillance of cases in their border districts as well as strengthening their capacity to test for cases and conduct surveillance in health facilities.  

WHO is also reaching out to Cote d’Ivoire, Mali, Senegal and other countries at risk in the region, the agency said.  

Ebola virus disease 

Ebola virus disease (EVD) is a rare but severe, often fatal illness in humans. The average EVD case fatality rate is around 50 per cent, with rates having varied from 25 per cent to 90 per cent in past outbreaks.  

The Ebola virus spreads through contact with the body fluids – such as vomit, faeces or blood – of an infected person, or through surfaces and materials (such as bedding, clothing) contaminated with these fluids. 

The incubation period, that is, the time interval from infection with the virus to onset of symptoms, is from two to 21 days. The symptoms of EVD can be sudden and include fever, fatigue, muscle, pain, headache, and sore throat.  

This is followed by vomiting, diarrhoea, rash, symptoms of impaired kidney and liver function, and in some cases internal and external bleeding. 

According to WHO, though there are no known treatments for Ebola, an Ebola vaccine rVSV-ZEBOV can offer protection against the deadly virus. In addition,  simple interventions early on can significantly improve chances of survival, including rehydration with fluids and body salts (given orally or intravenously), and treatment of specific symptoms. Hand hygiene is also a very effective way to prevent the spread of the virus. 

‘Constellation’ of post-COVID symptoms will impact global healthcare, says WHO 
‘Constellation’ of post-COVID symptoms will impact global healthcare, says WHO 

“We know that this post-COVID-19 condition – or as some patients also call it ‘long COVID’ and some clinicians call it ‘long COVID’ – is a heterogenous group of symptoms that occur after the acute illness”, said Dr. Janet Diaz, Team Lead, Health Care Readiness at WHO

“So, these are symptoms or complications that can happen potentially a month after, three months after, or even six months after, and as we are learning more, we are trying to understand the real duration of this condition.” 

Mental and physical ills are ‘real’ 

Citing reported symptoms such as neurological and physical illness, Dr. Diaz noted that an unspecified number of sufferers had been unable to return to work, once they had recovered from the acute sickness caused by the new coronavirus

“We are concerned obviously with the numbers of patients infected with SARS-CoV-2 virus that the numbers…just by the magnitude of the pandemic, will impact health systems.” 

Although comprehensive data on the condition is not yet available, the WHO official insisted that “these (symptoms) were real”.  

“Some of the “more common” ailments were “fatigue, exhaustion and post-exertional malaise, cognitive disfunction”, along with what some patients called “brain fog”, Dr Diaz said, describing a “constellation of symptoms”.  

Complications 

Further research is also needed to drill down into how many COVID-19 sufferers who did not require intensive care unit (ICU) treatment still went on to develop the condition. 

“What we know this far is that patients experiencing (a) post-COVID-19 condition could have been hospitalized patients, those in the ICU. So, we do know that has happened in patients who are very sick, but also in patients who were not managed inside the hospital…they have had complications and they have had persistent symptoms or new symptoms…or symptoms that waxed and waned, that came and went after their acute illness.” 

To promote a better understanding of post-COVID sickness and support patient care and public health interventions, the WHO has called on clinicians and patients to report data on symptoms to the Organization’s Clinical Platform.  

The case report form – which is available in multiple languages – has been designed to report standardized clinical data from individuals after they have left hospital or after recovering from acute illness. 

“What we don’t know is why it’s happening, so what is the pathophysiology … of this condition…the researchers are really working hard to get to the answers of these questions,” Dr. Diaz said. 

Vaccine deal inked 

In a related development, UN Children’s Fund UNICEF announced on Friday a deal to distribute the Pfizer-BioNTech COVID-19 vaccine, potentially before the end of March.  

The agreement is on behalf of the COVAX platform, primarily for developing nations, set up by the WHO,  The Coalition for Epidemic Preparedness Innovations (CEPI) and GAVI, the Vaccine Alliance. 

“This supply agreement allows UNICEF to procure up to 40 million doses that have been secured under the COVAX Facility’s Advance Purchase Agreement with Pfizer/BioNTech to be available throughout 2021”, the UN agency said in a statement.  

Emergency use approved 

The Pfizer-BioNTech jab was the first to receive WHO Emergency Use Listing (EUL) on 31 December 2020.  

It requires ultra-cold chain storage facilities which UNICEF has secured with partners to support governments in their roll-out of a variety of COVID-19 vaccines, it said. 

As of Friday 12 February 2021, WHO’s coronavirus tracker reported 107,252,265 confirmed cases of COVID-19, including 2,355,339 deaths. 

Regionally, the Americas have seen most cases to date, with 47,814,602 infections, followed by Europe (36,132,951), South-East Asia (13,141,859), Eastern Mediterranean (5,951,021), Africa (2,694,171) and Western Pacific (1,516,916).

‘Three major threats’ to inoculating the world – UN health agency
‘Three major threats’ to inoculating the world – UN health agency

Briefing UN Member States on Thursday, WHO chief Tedros Adhanom Ghebreyesus drew attention to a $27 billion financing gap in the ACT Accelerator, which supports the development and equitable distribution of coronavirus tests, treatments and vaccines globally. 

“The longer this gap goes unmet, the harder it becomes to understand why, given this is a tiny fraction of the trillions of dollars that have been mobilized for stimulus packages in G20 countries”, he said. 

Secondly, noting some bilateral deals, he called on all States “to respect COVAX contracts and not compete with them”. 

And third, Tedros underscored the need for “an urgent scale-up in manufacturing to increase the volume of vaccines” with “innovative partnerships” to include tech transfer, licensing and “other mechanisms to address production bottlenecks”. 

COVID swells in Africa  

Meanwhile, as Africa marks one year since its first COVID-19 case, on 14 February, WHO revealed that last month, the continent had witnessed a 40 per cent surge in COVID fatalities – pushing the death toll there towards 100,000. 

“The increasing deaths from COVID-19 we are seeing are tragic, but are also disturbing warning signs that health workers and health systems in Africa are dangerously overstretched”, WHO Regional Director for Africa Matshidiso Moeti said at a virtual press conference. 

‘Grim milestone’ 

At the same time, in the last 28 days, over 22,300 deaths were reported on the continent – a 3.7 per cent fatality rise – compared with nearly 16,000 deaths in the previous 28 days, which reflected a 2.4 per cent increase, according to WHO.  

This mortality spike comes as Africa’s second wave which began in October, seems to have peaked on 6 January, having spread significantly faster and proven far more lethal. 

WHO maintained that second wave cases surged far beyond the peak experienced in the first wave and health facilities have become overwhelmed. 

“This grim milestone must refocus everyone on stamping out the virus”, said Dr. Moeti. 

New strain, new challenges 

At the same time, new contagious COVID-19 strains are spreading rapidly as Africa gears up for its largest-ever vaccination drive. 

The variant known as B1.351, which was first identified in South Africa, has now been detected in eight African States, while the mutation initially identified in the United Kingdom, called B1.1.7, has been found in six countries on the continent. 

“This is obviously very disappointing news, but the situation is very dynamic”, said Dr. Moeti. “While a vaccine that protects against all forms of COVID-19 is our biggest hope, preventing severe cases which overwhelm hospitals is crucial”. 

This week South Africa said it would pause the roll-out of the Oxford/AstraZeneca vaccine citing a study indicating that it is less effective in battling the country’s dominant B1.351 strain. 

Coordinated approach needed 

WHO says there is an “urgent need” for a coordinated approach to variant surveillance and more evaluation to help decipher the potential impact they may have on vaccine effectiveness.  

“The pandemic is far from over, and vaccines are just one crucial tool in our fight against the virus. We must boost investments and support for our health workers and health systems by sticking to mask wearing, regular hand cleaning and safe social distancing”, said Dr Moeti.

COVID-19 ‘extremely unlikely’ to have come from a lab, experts say
COVID-19 ‘extremely unlikely’ to have come from a lab, experts say

Dr. Peter Ben Embarek from the World Health Organization (WHO) was speaking during a press conference in Wuhan, China, at the end of a four-week mission to the city where the new coronavirus first emerged in December 2019. 

“Our initial findings suggest that the introduction through an intermediary host species is the most likely pathway and one that will require more studies and more specific targeted research”, he said. 

Joint expert team 

The international team convened by WHO consisted of 17 Chinese experts and an equal number of counterparts from other nations, looking at three areas: epidemiology, molecular research and animal and environment. 

They visited hospitals and other sites in Wuhan, including the Huanan Market where the SARS-CoV-2 virus was first detected, and identified four main hypotheses of how it could have been transmitted to humans. 

“However, the findings suggest that the laboratory incident hypothesis is extremely unlikely to explain introduction of the virus into the human population, and therefore is not a hypothesis that implies to suggest future studies into our work, to support our future work, into the understanding of the origin of the virus”, Dr. Embarek said. 

Frozen food link? 

While ongoing research continues to suggest that bats are a natural reservoir for the new coronavirus, Dr, Embarek ruled out the possibility in Wuhan, as the city is not near to any environments where these animals are found. 

One hypothesis suggests the virus could have come through the food chain, as frozen products can provide a surface for transmission. 

Dr. Embarek said frozen animal products, mainly seafood, were sold at Huanan Market, along with products made from wild and farmed animals, some of which came from other parts of China or were imported.  

“So, there is the potential to continue to follow this lead and further look at the supply chain and animals that were supplied to the markets in frozen and other processed and semi-processed form, or raw form”, he said. 

Virus circulating elsewhere earlier 

It has been nearly a year since the COVID-19 pandemic was declared and as of Tuesday, there were more than 106 million cases worldwide, including some 2.3 million deaths. 

The investigations conducted in Wuhan will lay the groundwork for virus origin tracing elsewhere, according to the team’s Chinese lead, Dr. Liang Wannian. 

He said their review of unpublished studies suggests the virus was circulating earlier in other regions. 

“These studies from different countries suggests SARS-CoV-2 circulation preceding the initial detection of cases by several weeks”, said Dr. Liang, speaking through an interpreter. 

“Some of the suspected positive samples were detected even earlier than the first case reported. This indicates the possibility of the missed reported circulation in other regions.” 

Dr. Liang added that research also found “no indication” of virus transmission in Wuhan in the period before December 2019. 

Unless COVID is suppressed everywhere, we’ll be ‘back at square one’, Tedros warns
Unless COVID is suppressed everywhere, we’ll be ‘back at square one’, Tedros warns

“In one sense, that’s good news, and a remarkable achievement in such a short timeframe”, World Health Organization (WHO) chief, Tedros Adhanom Ghebreyesus told journalists at a regular press briefing in Geneva.  

However, he noted that “more than three quarters of those vaccinations are in just 10 countries that account for almost 60 per cent of global GDP”. 

This amounts to 130 countries, with 2.5 billion people, that have yet to administer a single dose. 

Share and protect 

Against the backdrop that some countries have even vaccinated some lower-risk populations, Tedros recognized that while all governments have an obligation to protect their own people, after inoculating their health workers and older people, “the best way to protect the rest of their own population is to share vaccines so other countries can do the same”. 

“Unless we suppress the virus everywhere, we could end up back at square one”, cautioned the WHO chief. 

Wanted: A massive production scale-up 

On Wednesday, the UN-led coronavirus vaccine initiative COVAX published its distribution forecast for participating States.  

Noting that “countries are ready to go, but the vaccines aren’t there”, Tedros again underscored the need for nations to share doses. 

“But we also need a massive scale-up in production”, he said. 

Drawing attention to French pharmaceutical giant Sanofi’s announcement last week to make its manufacturing infrastructure available to produce the Pfizer/BioNTech vaccine, he called on other companies to follow their example.  

“Companies can also issue non-exclusive licenses to allow other producers to manufacture their vaccine – a mechanism that has been used before to expand access to treatments for HIV and hepatitis C”, said the WHO chief. 

Having received substantial public funding, he stressed that “manufacturers can do more”. 

“We encourage all manufacturers to share their data and technology to ensure global equitable access to vaccines”, Tedros said. 

The WHO chief also called on companies to “share their dossiers” with the UN health agency faster and more fully than they have been doing, “so we can review them for emergency use listing”.

Consecutive drop in new COVID-19 cases ‘encouraging news’: WHO
Consecutive drop in new COVID-19 cases ‘encouraging news’: WHO

“There are still many countries with increasing numbers of cases, but at the global level, this is encouraging news”, said WHO chief Tedros Adhanom Ghebreyesus, speaking during the agency’s bi-weekly briefing from Geneva. 

“It shows this virus can be controlled, even with the new variants in circulation. And it shows that if we keep going with the same proven public health measures, we can prevent infections and save lives”. 

Stay the course 

While welcoming the development, Tedros recalled “we have been here before”, and warned against complacency. 

“Over the past year, there have been moments in almost all countries when cases declined, and governments opened up too quickly and individuals let down their guard, only for the virus to come roaring back”, he said. 

The WHO chief stressed that as vaccines are rolled out, people everywhere must continue to take measures aimed at keeping themselves, and others, safe. 

“It is vital that governments enable people to make the right choices, whether it is making quarantine easier to adhere to, or making workplaces safer,” he said.  

“Controlling the spread of the virus saves lives now, and saves lives later by reducing the chances of more variants emerging. And it helps to ensure vaccines remain effective.” 

Lack of data undermines response 

WHO has underscored the urgent need for better data to strengthen pandemic response and improve health outcomes, in a new report launched on Monday. 

The SCORE Global Report provides a snapshot of the state of health information systems around the world and is the first study of its kind. 

SCORE stands for Survey, Count, Optimize, Review and Enable, and the report covers 133 country health information systems and just under 90 per cent of the global population. 

It reveals that globally, four in10 deaths remain unregistered, while only one in 10 deaths is recorded in the African region. 

WHO said the lack of data worldwide limits understanding of the true mortality impact of the COVID-19 pandemic, which undermines response planning.

Scoring a goal against COVID-19 

The global football governing body, FIFA, is supporting the drive to make COVID-19 vaccines, treatments and diagnostics available to all countries. 

FIFA has teamed up with WHO for the “ACT Together” campaign, which also promotes adherence to the everyday public health measures aimed at preventing coronavirus spread, such as hand washing and wearing masks. 

Star footballers and competing team captains will participate in the campaign, which is being held in conjunction with the FIFA Club World Cup 2020, taking place in Qatar from 4-11 February. 

FIFA President Gianni Infantino emphasized the importance of having a level playing field, whether in football or in health. 

“Fairness and team spirit are key values of our sport,” he said. “And these same key values, fairness and team spirit are needed for today’s great challenge: overcoming COVID-19.” 

It is important for football to address issues that affect society, 2001 Ballon d’Or winner Michael Owen told the briefing, reminding that vaccine access must be fair and equitable. 

“This has been a global pandemic, and globally we need to give access to vaccination,” he said. 

Update on Wuhan mission  

Meanwhile, WHO Technical Lead on COVID-19, Dr. Maria Van Kerhkove, said the international mission on the ground in Wuhan, China, is having “very productive discussions” with counterparts there. 

The 15 experts arrived in the city last month to study the origins of the novel coronavirus, which causes the disease. 

Dr. Van Kerhkove reported that they have visited hospitals, as well as the market, and have met with officials from the Wuhan Centre for Disease Control (CDC) and the Chinese CDC. 

“Their focus is on the early cases and they are having very good discussions around that,” she said. 

The mission has attracted media attention and Dr. Van Kerhkove  underscored that the team must be given the space to carry out its work. 

Hopes of fresh momentum in fight against leprosy, but stigmatization persists
Hopes of fresh momentum in fight against leprosy, but stigmatization persists

“We should learn from the history of leprosy. To better fight against an epidemic or a pandemic, we must eliminate discrimination and double standards for those who have been systematically left behind”. This is the message from Alice Cruz, an independent UN rights expert, and Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members, on World Leprosy Day.

Setbacks likely, inaction blamed

Ms. Cruz notes that the consequences of the COVID-19 pandemic – which range from deprivation of the right to education, housing and employment, to domestic and sexual violence – mirror those experienced by sufferers of leprosy (also known as Hansen’s disease) over thousands of years.

In May 2020, the independent UN expert raised the alarm of the disproportionate effect that the pandemic is having on leprosy sufferers, in an open letter addressed to governments in which she called for detailed actions plans.

In her message for World Leprosy Day, Ms Cruz warned that an inadequate response from countries where the disease is prevalent, is likely to lead to a setback in leprosy control, transmission and prevention of disabilities, as well as in the worsening of an already extremely precarious standard of living.

Changing mindsets

Leprosy is curable, if treatment swiftly follows a timely diagnosis, but if patients are not treated, they can be left with irreversible physical impairments and disabilities. However, in his message for the Day, Yohei Sasakawa, the World Health Organization (WHO) Goodwill Ambassador for Leprosy Elimination, points out that early diagnosis of leprosy and prompt treatment are not enough to overcome the disease. 

“It also requires changing mindsets”, he says, “so that leprosy is no longer a source of shame or prejudice. We must remove all barriers in the way of those seeking medical care. We must eliminate the obstacles that prevent affected individuals and their families from living in dignity and enjoying all their basic human rights as full members of society”.

Mr. Sasakawa expressed confidence that the WHO’s Global Leprosy Strategy for 2021-2030 will generate new momentum in the fight against the disease, and looked forward to “an inclusive society in which everyone has access to quality treatment and services, and a diagnosis of leprosy no longer comes with a possibility of devastating physical, social, economic or psychological consequences”.
 

Follow the science: UN plans for a stronger pandemic recovery
Follow the science: UN plans for a stronger pandemic recovery

In her remarks to the event, Ms. Mohammed noted the far-reaching social, economic, and health impacts of the pandemic, the disproportionate effect that it has had on the most marginalized populations, and the 70 million extra people who have been pushed into poverty as a result of measures taken to curb the spread of the virus.

A new future’

COVID-19”, said the deputy UN chief, “has made it evident that we must build a new future through transformative changes that prioritize equity, resilience and sustainability”.

We must build a new future through transformative changes that prioritize equity, resilience and sustainability Amina Mohammed, Deputy Secretary-General

The Open Dialogue on Science for Development in the Context of COVID-19, billed as a first-of-its-kind event, was convened by the UN and the Canadian Institutes of Health Research, to highlight the importance of science and global collaboration. 

The discussions between the senior representatives of research institutions and senior UN officials were based on partnership strategies, including the UN Research Roadmap for the COVID-19 Recovery, released in November 2020.

With the virus exposing stark global inequities, the roadmap is designed to address the complex health, humanitarian and socio-economic consequences of COVID-19, while boosting speedy recovery efforts, and encouraging targeted research for data-driven responses that focus particularly on the needs of people being left behind. Many of the experts who contributed to the Roadmap also participated in the Open Dialogue.

CDC

A scientist tests a sample suspected of containing a bacterial toxin.

Closer collaboration

The event served as a stepping-stone towards the UN’s aim of ramping up progress towards the Sustainable Development Goals, and the 2030 Agenda for Sustainable Development, through closer collaboration between researchers, funding agencies, governments and civil society organizations, as well as UN entities.

“To succeed, we need solutions and global action that is focused, coordinated and unified”, declared Ms. Mohammed. “It will require new and strengthened partnerships across the global research community and between researchers, research funding organizations and the United Nations”. 
 

‘End the scourge of neglected tropical diseases’: UN health chief
‘End the scourge of neglected tropical diseases’: UN health chief

In a statement released by WHO, Tedros Adhanom Ghebreyesus declared that a new approach is needed if diseases such as guinea worm and yaws are to be tackled: “This means injecting new energy into our efforts and working together in new ways to get prevention and treatment for all these diseases, to everyone who needs it”.

10-year plan

This new approach was unveiled on Wednesday, in a 10-year plan which targets a 90 per cent reduction in the need for the treatment of neglected tropical diseases (NTDs). The plan contains several concrete proposals in areas such as programme delivery, cost-effectiveness and improved coverage, and calls for programmes to be sustainable, with measurable outcomes and adequate domestic financing.

As well as causing pain and disability, NTDs hinder economic development, by preventing children from going to school and adults from going to work. Those affected by disabilities and impairments caused by NTDs, often experience stigma within their communities, leading to social isolation.

© UNICEF/Anne Ackerman

A young boy receives treatment for Guinea worm disease in South Sudan.

Ambitious targets

The WHO plan, developed in consultation with a wide selection of countries, partners, stakeholders, scientists, and academics, contains several ambitious targets, including the elimination of a minimum of one NTD in at least 100 countries, completely eradicating guinea worm and yaws, and vastly improving access to basic water supply and sanitation.

The progress made in fighting NTDs over the last ten years is an encouraging indicator of what can be achieved in the coming decade, the UN health agency said.

Around 600 million fewer people are now at risk of these diseases; 42 countries have eliminated at least one NTD; and global programmes treated at least one billion people in the five year period between 2015 and 2020.

Significant threats still need to be overcome, however, including climate change, the threat of new diseases crossing over from animals to humans, conflict, and continued inequalities in access to healthcare services, adequate housing, safe water and sanitation.

Amidst surging COVID numbers, WHO chief urges: ‘take heart and take action’
Amidst surging COVID numbers, WHO chief urges: ‘take heart and take action’

Every death is someone’s parent, partner, child, or friend, Tedros Adhanom Ghebreyesus, head of the World Health Organiztion (WHO), told the briefing. He noted that exactly a year ago, fewer than 1,500 cases of COVID-19 had been reported.

‘Take heart, take hope’ 

Vaccines have given the world hope, which, according to the WHO chief is why “every life we lose now is even more tragic”. 

“We must take heart, take hope and take action”, he said, reiterating his call for health workers and older people in all countries to be vaccinated within the first 100 days of 2021. 

Brink of catastrophe 

Last week, Tedros said that the world stood on “the brink of a catastrophic moral failure” if it does not deliver equitable access to vaccines.  

Two new studies show that “it wouldn’t just be a moral failure, it would be an economic failure” too, he said. 

An International Labour Organization (ILO) analysis released on Monday, found that $3.7 trillion was lost last year in terms of working hours. 

While the report projected that most countries will recover in the second half of 2021, depending on vaccination rollout, it recommends international assistance for low and middle income countries to support vaccine rollout and promote economic and job recovery programmes. 

At the same time, a study commissioned by the International Chamber of Commerce Research Foundation, makes a strong economic case for vaccine equity.  

“It finds that vaccine nationalism could cost the global economy up to $9.2 trillion, and almost half of that – $4.5 trillion – would be incurred in the wealthiest economies”, the WHO chief said. 

Growing vaccine divide   

Meanwhile a financing gap for the Access to COVID-19 Tools Accelerator this year stands at $26 billion, according to the UN official, saying that if fully funded, it would return up to $166 “for every dollar invested”. 

While so-called vaccine nationalism “might serve short-term political goals”, he upheld that it is in every nation’s own medium and long-term economic interest to support “vaccine equity”, reminding that until the pandemic is ended everywhere, it won’t be eradicated anywhere. 

“As we speak, rich countries are rolling out vaccines, while the world’s least-developed countries watch and wait”, he said. “Every day that passes, the divide grows larger between the world’s haves and have nots”. 

Sri Lanka: ‘Forced’ cremation of COVID victims’ bodies must stop - UN rights experts
Sri Lanka: ‘Forced’ cremation of COVID victims’ bodies must stop – UN rights experts

In a joint appeal, Special Rapporteurs Ahmed Shaheed, Fernand de Varennes, Clément Nyaletsossi Voule and Tlaleng Mofokeng, said that the practice ran contrary to the beliefs of Muslims and other minorities.

It ran the risk of increasing prejudice, intolerance and violence, they said in a statement, insisting that no medical or scientific evidence indicated that burying the deceased increased the risk of spreading communicable diseases such as COVID-19.

To date, more than 270 COVID-19 deaths have been reported in Sri Lanka; a significant number have come from the minority Muslim community.

All of the deceased were cremated in line with amended health guidelines for COVID-19 patients, which were issued on last March.

‘Aggressive nationalism’

“We deplore the implementation of such public health decisions based on discrimination, aggressive nationalism and ethnocentrism amounting to persecution of Muslims and other minorities in the country” the experts said.

“Such hostility against the minorities exacerbates existing prejudices, intercommunal tensions, and religious intolerance, sowing fear and distrust while inciting further hatred and violence”, they added.

“We are equally concerned that such a policy deters the poor and the most vulnerable from accessing public healthcare over fears of discrimination”, they said, noting that it would further negatively impact the public health measures to contain the pandemic.

‘Immediate’ cremation

Information received by the experts indicates that cremation often takes place immediately after test results are provided, without granting family members reasonable time or the opportunity to cross check or receive the final test results.

There have been several cases of cremations based on erroneous information about COVID-19 test results, the experts said.

They noted that the President and Prime Minister had instructed the health authorities to explore options for burials in Sri Lanka.

Disregard

“However, we are concerned to learn that the recommendation to include both cremation and burial options for the disposal of bodies of COVID-19 victims by a panel of experts appointed by the State Minister for Primary Health Services, Pandemics and COVID Prevention, was reportedly disregarded by the Government”, they said.

“We strongly urge the Government of Sri Lanka to stop the forced cremation of COVID-19 bodies, to take all necessary measures to combat disinformation, hate speech and stigmatization” of Muslims and other minorities, “as a vector of the pandemic, and to provide remedy and ensure accountability for cremations that were carried out by error.”

Special Rapporteurs and independent experts are appointed by the Geneva-based UN Human Rights Council and are neither UN staff nor paid for their work.

Pandemic will not end for anyone, ‘until it ends for everyone’ 
Pandemic will not end for anyone, ‘until it ends for everyone’ 

“The virus can still travel from the vastly unvaccinated massive population of the Global South to the Global North, including in its increasingly mutating forms”, Obiora Okafor, UN Special Rapporteur on human rights and international solidarity, said in a statement

He explained that with mutations constantly evolving, only inoculating rich countries would likely “complicate or delay” the eradication of the virus. 

Skewed vaccine delivery 

The last few weeks of 2020 witnessed the approval of several COVID-19 vaccines by regulators in various countries, “offering much hope to billions of people worldwide”, according to the UN expert.  

And while several States, mostly in the north, have already secured large quantities of vaccine and have begun inoculation campaigns, this has not been the case for most of the Global South, where close to 90 per cent of the world’s population lives. 

“The world, therefore, faces a sharp and highly problematic vaccine-divide in which the much richer Global North States, which host a very small percentage of the global population, have so far cornered the vast majority of available COVID-19 vaccines, leaving the bulk of the world’s population with almost no access to these medicines”, Mr. Okafor said.  

“A globally coordinated vaccine distribution programme is highly preferable to the individualized approaches adopted by all-too-many of the richer States”, Mr. Okafor said. 

International vaccine solidarity  

He said it was vital that States and non-State actors cooperate – such as through the COVID-19 Vaccine Global Access Facility (COVAX), which, led by the World Health Organization (WHO), is part of the Access to COVID-19 Tools (ACT) Accelerator – or risk a stalled recovery. 

While noting that COVAX aims to fairly distribute two billion vaccine doses by the end of 2021, Mr. Okafor emphasized that “international vaccine solidarity” be favored over “international vaccine competition”. 

“Given the great urgency of ensuring for everyone, everywhere, as rapid and effective access to COVID-19 vaccines as possible, I, therefore, urge urgent and strong action by States and other actors toward a course correction”, he said. 

Click here for the names of the UN experts who endorsed the statement. 

Fair access for migrants 

Separately, UN independent experts González Morales and Tlaleng Mofokeng have urged States to ensure that migrants are also included in national COVID vaccination programmes, saying that global immunization access for everyone who needs them “is the only solution” to ending the pandemic. 

This includes priority groups of vulnerable people “regardless of who they are” or their migration status, said the rights experts. 

They also called on world leaders to refrain from discriminatory discourse that could lead to the exclusion of migrants in irregular situations from the global public health response. 

Special Rapporteurs and independent experts are appointed by the Geneva-based UN Human Rights Council and are neither UN staff nor paid for their work.  

Fauci announces US intention to resume major role in global health
Fauci announces US intention to resume major role in global health

Addressing the WHO’s Executive Board Meeting, Dr. Anthony Fauci, Chief Medical Adviser to the new US President, said that Mr. Biden intended to issue a directive within hours so that the country can become part of the COVAX platform to advance multilateral efforts to distribute coronavirus vaccines, therapeutics and diagnostics. 

Speaking one year ago “to the day” since the United States confirmed its first case of COVID-19 infection, Dr. Fauci noted that global infections had now surpassed 90 million.

This was a “devastating number that continues to grow”, he said, while paying tribute to the scientists, public health officials and frontline healthcare workers, and community health workers who had worked “heroically” to fight the virus.

They had developed medical countermeasures “at truly phenomenal speed, adapting their responses as more is known about the virus, he said, “courageously treating the millions of people who have been stricken by this historic scourge”. 

‘Committed to transparency’ 

Dr. Fauci noted that responding to COVID-19 and “rebuilding global health and advancing health security” worldwide, “will not be easy.” 

He said the US was “committed to transparency, including those events surrounding the early days of the pandemic. It is imperative that we learn and build upon important lessons about how future pandemic events can be averted”, he added. “The international investigation should be robust and clear, and we look forward to evaluating it”. 

Global health gains 

Addressing the WHO executive, Dr. Fauci also announced US plans to work with other countries “to counter the erosion of major gains in global health”, specifying HIV/AIDS, food security, malaria and epidemic preparedness. 

“It will be our policy to support women’s and girls’ sexual and reproductive health and reproductive rights in the United States, as well as globally”, the US official added.   

In reference to existing US federal policy which blocks funding for organizations that provide counselling on abortion or related services, he explained that President Biden “will be revoking” it “in the coming days”, as part of his broader commitment to protect women’s health and advance gender equality at home and around the world.” 

As a WHO member, the United States would also work “constructively…to strengthen and importantly reform the WHO”, Dr. Fauci said, helping to lead the collective effort to strengthen the international COVID-19 response and address its impacts on people, communities, and health systems everywhere. 

A family of nations: WHO chief Tedros 

Welcoming the US pledge to fully rejoin WHO, Director-General Tedros Adhanom Ghebreyesus said he “looked forward to continuing this partnership, as I know all [WHO] Member States do.” 

Tedros extended his best wishes to Dr. Fauci, President Biden, Vice President Harris, the new administration, and the American people “as you work together to save lives and bring the pandemic under control.” 

“I assure you of WHO’s continued commitment to support you with science, solutions, solidarity and service” he said. 

“WHO is a family of nations. And we are all glad that the United States is staying in the family”, Dr. Tedros added. 

Financial boost 

The head of US delegation, Dr. Fauci also announced that his country will cease the drawdown of US staff seconded to the WHO and will resume regular engagement of US Government personnel directly and through its WHO Collaborating Centres. 

In addition, it intends to fulfil its financial obligations to the organization, he said.

Guterres urges world to ‘work together in solidarity’ as US moves to re-join WHO
Guterres urges world to ‘work together in solidarity’ as US moves to re-join WHO

In a statement issued by his spokesperson, Secretary-General António Guterres said that supporting the UN health agency “is absolutely critical” to the world’s effort for a better coordinated response against COVID-19

The UN chief also urged global solidarity to defeat the coronavirus.  

“Now is the time for unity and for the international community to work together in solidarity to stop this virus and its shattering consequences,” the statement added. 

Earlier in the day, in one of his first acts as new US President, Mr. Biden signed an executive order to stop the country’s departure from WHO, reversing the July 2020 decision by former president Donald Trump. Mr. Trump’s decision would have taken effect in July 2021, as the formal withdrawal requires a one-year notice. 

Mr. Trump had also halted funding for WHO in April last year, prompting global concerns for the UN’s health agency’s work in the midst of the coronavirus pandemic.  

The US is the largest donors to the agency, contributing almost $893 million for its programmes in 2018-2019.  

Joining the COVAX facility 

Alongside, the new administration announced US’s participation in the COVAX facility, a global effort co-led by WHO that aims to provide low income nations with COVID-19 vaccines. 

Mr. Guterres hailed the step, stressing “with vaccines being a critical tool in the battle against COVID-19, the United States joining and supporting the COVAX facility will give momentum to efforts to ensure equitable access to vaccines for all countries.” 

The vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-Accelerator), COVAX is a global mechanism that aims to ensure that people in all corners of the world will get access to COVID-19 vaccines, regardless of their wealth.   

Dr. Fauci to lead US delegation to WHO 

Also on Wednesday, a spokesperson for the US President announced that infectious disease expert Dr. Anthony Fauci will lead the country’s delegation to the ongoing WHO Executive Board meeting, participating remotely.  

The Biden administration also announced a series of actions to combat coronavirus, including requiring the use of facemasks in all federal buildings, lands, and on certain modes of public transport.

Over 1.9 billion people in Asia-Pacific unable to afford a healthy diet: UN report
Over 1.9 billion people in Asia-Pacific unable to afford a healthy diet: UN report

According to the 2020 Regional Overview of Food Security and Nutrition, the region’s poor have been worst affected, forced to choose cheaper and less nutritious foods. The report is jointly produced by the Food and Agriculture Organization (FAO), the UN Children’s Fund (UNICEF), the World Food Programme (WFP) and the World Health Organization (WHO). 

“The outbreak of COVID-19 and a lack of decent work opportunities in many parts of the region, alongside significant uncertainty of food systems and markets, has led to a worsening of inequality, as poorer families with dwindling incomes further alter their diets to choose cheaper, less nutritious foods,” the agencies said

“Due to higher prices for fruits, vegetables and dairy products, it has become nearly impossible for poor people in Asia and the Pacific to achieve healthy diets, the affordability of which is critical to ensure food security and nutrition for all – and for mothers and children in particular.” 

As a result, progress is also slowing on improving nutrition, a key target for the Sustainable Development Goals (SDGs). As of 2019, over 350 million people in the region are estimated to have been undernourished, with an about 74.5 million children under five stunted (too short for their age) and 31.5 million suffering from wasting (too thin for height). 

‘Impact most severe in first 1,000 days’ 

The UN agencies went on to note that while nutrition is vitally important throughout a person’s life, the impact of a poor diet is most severe in the first 1,000 days, from pregnancy to when a child reaches the age of two. 
“Young children, especially when they start eating their ‘first foods’ at six months, have high nutritional requirements to grow well and every bite counts,” they said. 

The agencies called for an integrated systems approach – bringing together food, water and sanitation, health, social protection and education systems – to address underlying factors and achieve healthy diets for all mothers and children. 

‘Changing face of malnutrition’ 

They also highlighted the “changing face” of malnutrition, with highly processed and inexpensive foods, readily available throughout Asia and the Pacific. Often packed with sugar and unhealthy fats, such food items lack the vitamins and minerals required for growth and development and also increase the risk of obesity, diabetes and cardiovascular disease. 

The report urged governments to invest more in nutrition and food safety to promote healthy diets, as well as regulate sales and marketing of food for consumers, especially children. It also highlighted the need for action within the private sector, given the sector’s important role in the food system and its value chains for achieving healthy diets. 

Independent panel finds critical early failings in COVID-19 response
Independent panel finds critical early failings in COVID-19 response

The Independent Panel for Pandemic Preparedness and Response found critical elements to be “slow, cumbersome and indecisive” in an era when information about new disease outbreaks is being transmitted faster than countries can formally report on them. 

“When there is a potential health threat, countries and the World Health Organization must further use the 21st century digital tools at their disposal to keep pace with news that spreads instantly on social media and infectious pathogens that spread rapidly through travel”, said Helen Clark, former Prime Minister of New Zealand and co-chair of the panel.   

“Detection and alert may have been speedy by the standards of earlier novel pathogens, but viruses move in minutes and hours, rather than in days and weeks.”  

‘Lost opportunities’ at the outset 

The Independent Panel was established to review lessons learned from international response to COVID-19, which first emerged in Wuhan, China, in December 2019. Nearly 94 million confirmed cases and more than two million deaths have been reported globally as of Tuesday. 

The panel’s second progress report said countries were slow to respond to the new coronavirus disease, noting “there were lost opportunities to apply basic public health measures at the earliest opportunity”. 

Although WHO declared on 30 January 2020 that COVID-19 was a Public Health Emergency of International Concern (PHEIC), the panel found many countries took minimal action to prevent spread both within and beyond their borders. 

“What is clear to the Panel is that public health measures could have been applied more forcefully by local and national health authorities in China in January”, the report said.  

“It is also clear to the Panel that there was evidence of cases in a number of countries by the end of January 2020. Public health containment measures should have been implemented immediately in any country with a likely case. They were not.” 

The report also outlined critical shortcomings at each phase of response, including failure to prepare for a pandemic despite years of warning.  

“The sheer toll of this epidemic is prima facie evidence that the world was not prepared for an infectious disease outbreak with global pandemic potential, despite the numerous warnings issued that such an event was probable”, it said. 

Deepening inequalities 

Pandemic response has also deepened inequalities, according to the panel, with inequitable access to COVID-19 vaccines a glaring example as rollout has favoured wealthy nations. 

“A world where high-income countries receive universal coverage while low-income countries are expected to accept only 20 per cent in the foreseeable future is on the wrong footing – both for justice and for pandemic control. This failure must be remedied”, said the panel’s co chair, Ellen Johnson Sirleaf, former President of Liberia. 

The report further highlighted the need to strengthen the UN’s health agency. 

“The WHO is expected to validate reports of disease outbreaks for their pandemic potential and, deploy support and containment resources, but its powers and funding to carry out its functions are limited”, Ms. Sirleaf said. “This is a question of resources, tools, access, and authority.”   

Countries are also urged to ensure testing, contact tracing and other public health measures to reduce virus spread, are being implemented, in efforts to save lives, particularly as more infectious virus variants emerge. 

The Independent Panel began its review last September and will present a report to the World Health Assembly, the decision-making body of WHO, in May.

Health experts arrive in Wuhan to investigate COVID-19 origins
Health experts arrive in Wuhan to investigate COVID-19 origins

Tedros Adhanom Ghebreyesus, the WHO Director-General, was addressing the latest session of the Emergency Committee on COVID-19 established under the International Health Regulations (IHR), a treaty that guides global response to public health risks. 

The new coronavirus that sparked the pandemic first emerged in Wuhan in December 2019.  Tedros reported that most of the 15 members of the delayed mission are now in the city, although two people are still in Singapore awaiting COVID-19 test results. 

“All members of the team had multiple negative PCR and antibody tests in their homes countries prior to traveling”, he said. 

“The team members who have arrived in Wuhan will be in quarantine for the next two weeks, and will begin working remotely with counterparts in China. They will then continue their work on the ground for a further two weeks.” 

Focus now on vaccine equity, travel prospects 

Thursday marked the sixth meeting of the IHR Emergency Committee on COVID-19.   

Members first convened a year ago, when there were less than 560 cases of the new disease. Today, more than 90 million cases have been reported globally, and the death toll has almost reached two million. 

Tedros said although the rollout of COVID-19 vaccines represents “hope of light at the end of the tunnel”, focus is now on ensuring all countries can access them on an equitable basis. 

He also highlighted two urgent issues for the committee’s attention: the recent emergence of multiple new variants of the virus, and the potential use of vaccination and testing certificates for international travel. 

“One theme ties both issues together: solidarity”, said Tedros.  “We cannot afford to prioritize or punish certain groups or countries. We are all in this together, and we must all come out of it together.” 

Challenges in Africa 

Meanwhile, the UN agency has warned of the need to avert a “runaway surge” of infections in Africa, as cases there top three million and new variants of the virus emerge on the continent. 

COVID-19 cases have risen steadily since mid-September, with a steeper rise from late November, and could increase in the wake of the Christmas and New Year holidays due to travel and festive gatherings. 

Dr. Matshidiso Moeti, WHO Regional Director for Africa, said although virus mutations are not surprising, preliminary analysis reveals that a new variant circulating widely in South Africa, known as 501Y.V2, is more transmissible.  

“Even if the new variant is not more virulent, a virus that can spread more easily will put further strain on hospitals and health workers who are in many cases already overstretched”, she said.  

“This is a stark reminder that the virus is relentless, that it still presents a manifest threat, and that our war is far from won.” 

WHO is supporting African countries with reinforcing genome sequencing efforts, key to finding and understanding new COVID-19 variants. 

So far, 501Y.V2 has been identified in Botswana, the Gambia and Zambia, while Nigeria is further investigating another variant found in samples collected in August and November.   The virus variant circulating in the United Kingdom has not been reported on the continent.

Step up vigilance for emerging coronavirus variants, WHO urges
Step up vigilance for emerging coronavirus variants, WHO urges

Alongside monitoring, virus and serum samples should be shared via globally agreed mechanisms so that critical research can be promptly initiated each time, according to the agency. 

“Our collective goal is to get ahead of the game and have a global mechanism to quickly identify and study variants of concern and understand their implications for disease control efforts,” said Ana Maria Henao Restrepo, Head of WHO’s R&D Blueprint

She was speaking at a virtual meeting of scientists from around the globe, convened by the UN health agency, attended by over 1,750 experts from 124 countries. 

Participants noted the importance of research to detect and understand early on the potential impact of emerging variants on diagnostics, treatments and vaccines, and highlighted the importance of integrating new SARS-CoV-2 variants research into the global research and innovation agenda, according to WHO. 

Normal for viruses to mutate 

It is normal for viruses to mutate, but the more the SARS-CoV-2 virus spreads, the more opportunities it has to change. High levels of transmission mean emergence of more variants should be expected, according to WHO.  

Of the significant variants reported so far, some are associated with increases in transmissibility but not disease severity. Research is ongoing to address whether the changes impact public health tools and measures. 

“So far an astounding 350,000 sequences have been publicly shared, but most come from just a handful of countries. Improving the geographic coverage of sequencing is critical for the world to have eyes and ears on changes to the virus,” said Maria Van Kerkhove, WHO Technical Lead on COVID-19

New variants of the coronavirus have been detected in the UK, South Africa and Japan, which appear to be more transmissible, although health officials have said that there is no evidence it is more deadly, or that it would not respond in the same way to the vaccines cleared for emergency use.

Information sharing critical 

Genomic sequencing has been critical in identifying and responding to new variants, and increasing sequencing capacity across the world is a priority research area for WHO. 

Better surveillance and laboratory capacity to monitor strains of concern needs to be accompanied by prompt sharing of virus and serum samples via globally agreed mechanisms so that critical research can be promptly initiated each time, the agency added.